We’ll be back on Monday morning with more fresh content!

In this final video of a three-part video series, Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and a ...

Sexual and gender minority individuals still face insurance denials and cost-sharing barriers when accessing pre-exposure ...

In this second part of a three-part of a video series, Kasey Raetz, Pharm.D., a PBMI Innovator, told MHE about leading the ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The next step for the Rise For Health study researchers is to study the health benefits of frequent standing in older men and ...

To help Medicare plans better manage members with high drug expenses, Prime Therapeutics has launched an AI-driven tool to ...

Developed by Ionis Pharmaceuticals, Dawnzera is the first RNA-targeted medicine approved for HAE, designed to target plasma ...

Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...

Prefilled syringes of Imuldosa now have the lowest wholesaler acquisition cost among all branded ustekinumab biosimilars, ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive (MHE) editorial advisory board, is host of the ...

Tonmya is the first new fibromyalgia treatment approved by the FDA in more than 15 years, providing symptom relief for at ...